FIRST TIME VISITOR? CLICK HERE!

Welcome to AIDS-Drugs-Online.com

Our website ensures an easy ordering process for affordable HIV/AIDS and PrEP medications, as well as protection of our customers' information. Having an account on our website allows you to place your orders easily, upload your prescriptions safely, view your order history, and even earn discounts.

If you have not ordered from us before:
You can create an account for free by clicking here.

Please take a moment to learn how to order. If you have any trouble, please call us at 1-888-243-7675.

Australia: +61 (2) 90537441 Switzerland: +41 (44) 7982088

We invite you to explore our website and save money on your HIV/AIDS and PrEP medications!


Evotaz 300/150 Mg
30 tablet(s)

Evotaz 300/150 Mg

$799.99 USD
+ shipping and handling
0 Review(s)

Prescription required

Active Ingredient(s): atazanavir/cobicistat
Manufacturer: Bristol-Myers Squibb Co.
Brand: Yes
Country of origin: Canada
30 tablet(s)
Active Ingredient(s): atazanavir/cobicistat
Manufacturer: Bristol-Myers Squibb Co.
Brand: Yes
Country of origin: Canada
Knows Names:

What is Evotaz (Atazanavir/Cobicistat)?

Evotaz is a combination formulation of the HIV Protease Inhibitor (PI) atazanavir (300mg) and pharmacokinetic enhancer cobicistat (150mg). Atazanavir is active against both mutant and wild-type HIV-1. Cobicistat on its own has no antiviral activity. This drug is used in the treatment of HIV-1 infection in combination with other antiretroviral drugs, usually including low-dose ritonavir. Atazanavir is not active against HIV-2. It works by blocking HIV protease from its function in producing mature virions.

Dosing & Administration

Evotaz is indicated for the treatment of HIV-1 infection in adults and is used off-label in treatment-naïve adolescents in late puberty. The medication comes in a film-coated tablet and should be taken with food. Dosing instructions and considerations are given in detail in the product monograph.

Evotaz pills should not be used in patients with any degree of liver dysfunction. No dosage adjustments are necessary for patients with renal impairment, but Evotaz should not be used in patients requiring hemodialysis. As well, the drug should not be used in patients with a creatinine clearance less than 70 mL/min if they are also taking tenofovir disoproxil fumarate.

Contraindications

Evotaz HIV medication is contraindicated in patients with hypersensitivity to the drug, and in patients with liver dysfunction. The drug is contraindicated for use with a number of medications and herbals listed in the product monograph.

Evotaz Side Effects

Evotaz can cause serious liver and heart rhythm side effects.

Other potential adverse effects include:

  • lactic acidosis syndrome,
  • viral resistance,
  • hepatotoxicity,
  • elevated cholesterol,
  • pancreatitis,
  • rash,
  • jaundice,
  • renal calculi,
  • hyperglycemia,
  • fat redistribution.

A complete list of potential adverse effects is provided in the product monograph.

Precautions

Evotaz should be used with caution in the presence of cardiac AV block, as atazanavir may prolong the PR interval or QTc in some patients. Patients with pre-existing cardiac abnormalities should be carefully screened prior to starting on Evotaz. This medicine should be used with caution in hemophiliacs due to increased bleeding risk with atazanavir. Screening and monitoring guidelines are provided in the product monograph.

All patients who test positive for HIV infection should be screened for comorbid Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infection. Co-infected patients should be started on an antiretroviral regimen targeting co-infected viruses, regardless of CD4 counts or viral loads. Current HIV treatment guidelines outline drug regimens and prescribing considerations.

Drug Interactions

Evotaz is associated with a large number of drug-drug interactions and contraindications, especially medications that are metabolized by CYP3A. A complete list is provided in the product monograph.

Pregnancy & Lactation

Highly active retroviral combination treatment should be used in all pregnant women. The safety of Evotaz pills in pregnancy has not been established. Current guidelines should be consulted when treating women in pregnancy. The drug is excreted in breast milk. The CDC recommends that all HIV positive women, treated or untreated, avoid breastfeeding to prevent vertical transmission of the virus.

Overdosage

There is no treatment that is specific for Evotaz overdose. Patients should be closely monitored and provided with supportive care. This medication is probably not removed by hemodialysis.

There are no reviews yet
Be the first to review “Evotaz 300/150 Mg”
Star

Reviews are only written by verified customers who have purchased this product.

Related Products

Tenvir EM 200/300 Mg

Tenvir EM 200/300 Mg

from $65.00 USD
Abamune-L 600/300 Mg

Abamune-L 600/300 Mg

from $98.00 USD
Viraday 600/200/300 Mg

Viraday 600/200/300 Mg

from $98.00 USD
Efavir 600 Mg

Efavir 600 Mg

from $65.00 USD

Reset your password

Please enter your email below, and we will send you a new password.

Still having trouble signing in?

If you're unable to reset your password, please call Customer Service at 1-888-243-7675.